Predictive Biomarker Validation
Predictive Biomarker Validation is the systematic assessment of a biomarker's ability to accurately forecast the future occurrence or risk of a specific clinical outcome, such as gestational diabetes, through rigorous statistical, experimental, and translational evaluation in well-defined populations.
210
Publications
11.1K
Citations
2.2K
Authors
839
Institutions
Publications per year
2017–2026
127
210
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
Dan Sha, Zhaohui Jin, Jan Budczies et al. · Cancer Discovery · 2020 · 866 citations · Full text
Medicine, Immunology, Oncology +17
Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber et al. · JAMA Oncology · 2018 · 238 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 210
2.2K
3
h-index
3
h-index
The University of Texas MD Anderson Cancer Center, United States
3 publications · 234 citations
3
h-index
3
h-index
3
h-index
1–5 of 2.2K
839
The University of Texas MD Anderson Cancer Center
Houston, United States
9 h-index
65 publications
5K citations
Inserm
Paris, France
8 h-index
29 publications
3.4K citations

Sun Yat-sen University
Guangzhou, China
7 h-index
29 publications
1K citations

Roswell Park Comprehensive Cancer Center
Buffalo, United States
6 h-index
19 publications
492 citations
University of Pennsylvania
Philadelphia, United States
6 h-index
18 publications
1.1K citations
University of Washington
Seattle, United States
6 h-index
12 publications
717 citations

Icahn School of Medicine at Mount Sinai
New York, United States
6 h-index
37 publications
1K citations
Hôpital Européen Georges-Pompidou
Paris, France
6 h-index
11 publications
485 citations
1–8 of 839
9 publications · 773 citations
9
h-index
8 publications · 186 citations
8
h-index
7 publications · 319 citations
7
h-index
Repository · 6 publications · 103 citations
6
h-index
4 publications · 242 citations
4
h-index
1–5